Nástroje

iconicon Akciový screener
iconicon Kalendář zisků
iconicon Super investoři

Ostatní

iconicon Návod
IČ: 19940963

5. května 521, 501 01 Turnov
Zásady GDPR
Podmínky služby
Všechna práva vyhrazena @ 2024, Fundamenty.cz
Proudly created by draftspot.net
CureVac N.V.
CureVac N.V.
CVAC
Valuace
70
Růst
0
Zdraví
75
Cena
$ 5.23
Dnes
0.00 (0.00%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.2B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
33%
ROA
28%
PE
8
PS
15
Cena 1R
2-6
⌀ Cena
4.85
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
25-11-2025
Poslední dividenda

Profil

CureVac N.V., biofarmaceutická společnost v klinickém stadiu, se zaměřuje na vývoj různých transformativních léčiv na bázi ribonukleové kyseliny messenger (mRNA). Vyvíjí profylaktické vakcíny, jako jsou mRNA kandidáty na vakcínu CV2CoV, která je ve fázi 1 klinické studie proti SARS-CoV-2; CV7202, profylaktická mRNA vakcína, která dokončila fázi 1 klinické studie pro vzteklinu glykoprotein; a CVSQIV, která je ve fázi 1 klinické studie proti chřipce, stejně jako vakcína proti lassa, žluté zimnici, respirační syncytiální virus, rotavirus, malárie a univerzální chřipka. Společnost také vyvíjí rakovinné imunoterapie založené na RNA, včetně CV8102, který je ve fázi 1 klinické studie pro léčbu kožního melanomu a adenoidcystického karcinomu, stejně jako dlaždicobuněčného karcinomu kůže, hlavy a krku. Společnost byla založena v roce 2000 a sídlí v německém Tübingenu.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
825
Založení
2020-08-14
Adresa
Friedrich-Miescher-Strasse 15
CEO
Alexander Zehnder
Web
www.curevac.com

Podobné společnosti

NVAX
Novavax, Inc.
$ 7.16
- $ 0.28
NKTR
Nektar Therapeutics
$ 56.14
+ $ 0.17
SNDX
Syndax Pharmaceuticals, Inc.
$ 15.95
+ $ 0.91
INBX
Inhibrx Biosciences, Inc.
$ 77.02
- $ 3.67
AMLX
Amylyx Pharmaceuticals, Inc.
$ 12.21
- $ 0.10
IMTX
Immatics N.V.
$ 9.14
+ $ 0.09
RLAY
Relay Therapeutics, Inc.
$ 6.24
+ $ 0.19

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2024202320222021202020192018
Total Revenues70.7535.253.867.4103.048.917.412.9
Cost of Revenues4.9105.8124.4184.0238.214.228.017.7
Gross Profit65.8429.4-70.6-116.6-135.234.7-10.6-4.9
Revenue 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Revenues54.11.20.914.5493.914.412.422.016.57.6
Cost of Revenues0.42.20.91.521.940.741.759.824.325.9
Gross Profit53.8-1.00.013.0472.0-26.3-29.3-37.8-7.8-18.3
Operating Income TTM 2024202320222021202020192018
R&D Expenses0.00.0115.762.6815.9113.843.241.7
Selling General & Admin Expenses0.00.076.489.488.945.843.921.5
Depreciation & Amortization17.618.823.426.425.814.28.03.8
Total Operating Expenses-84.2251.7203.6134.3277.1158.788.968.0
Operating Income150.0177.7-274.2-249.5-412.3-124.0-99.5-72.8
Operating Income TTM 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
R&D Expenses0.00.00.00.00.00.00.029.427.230.9
Selling General & Admin Expenses0.00.00.00.00.00.00.023.316.019.1
Depreciation & Amortization4.44.44.64.34.55.15.19.16.35.8
Total Operating Expenses-256.560.854.756.7103.647.344.952.646.753.7
Operating Income310.2-61.7-54.7-43.8368.4-73.6-73.3-90.4-54.0-71.8
Net Income TTM 2024202320222021202020192018
Interest Income13.312.416.74.010.12.10.82.0
Interest Expense7.20.02.53.710.322.11.50.3
Other Expense7.413.214.20.3-0.2-5.8-0.61.7
IBT157.4190.9-260.0-249.2-412.5-129.8-100.1-71.1
Income Tax Expense28.628.70.2-0.1-0.8-0.7-0.30.1
Net Income128.8162.2-260.2-249.0-411.7-129.1-99.9-71.2
Net Income TTM 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Interest Income3.82.33.43.72.32.53.80.09.46.2
Interest Expense6.90.60.3-0.60.10.20.30.04.11.8
Other Expense-2.61.83.15.22.22.43.41.55.44.4
IBT307.6-60.0-51.7-38.6370.6-71.2-69.9-84.3-48.7-67.4
Income Tax Expense34.4-0.40.4-5.832.51.30.70.20.00.0
Net Income273.2-59.6-52.1-32.8338.0-72.5-70.6-84.4-48.7-67.4
Per Share Data TTM 2024202320222021202020192018
EPS$0.00$0.00$-1.18$-1.32$-2.21$-0.72$-0.57$-0.40
EPS Diluted$0.00$0.00$-1.18$-1.32$-2.21$-0.72$-0.57$-0.40
Shares Outstanding225.2224.4220.5189.1186.0180.5176.0176.0
Diluted Shares Outstanding225.2225.3220.8189.1186.0180.5176.0176.0
Per Share Data TTM 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.38$-0.22$-0.30
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.38$-0.22$-0.30
Shares Outstanding225.2225.2225.2224.3224.3224.3224.3224.0223.9223.9
Diluted Shares Outstanding225.2225.2225.2224.8224.3224.3224.3224.0223.9223.9
Current Assets TTM 2024202320222021202020192018
Cash And Equivalents202.6481.7402.5495.8811.51,322.630.721.4
Short Term Investments3.73.62.74.54.62.61.539.3
Total Cash & ST Investments202.6485.4405.1500.3816.11,325.232.160.6
Accounts Receivable34.832.939.539.418.51.817.76.9
Inventory0.50.524.824.056.214.56.23.0
Other Current Assets13.87.69.05.349.248.31.22.6
Total Current Assets251.7526.4478.4584.0940.01,389.957.273.1
Current Assets 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Cash And Equivalents392.7438.3481.7550.9202.5300.2402.8464.1537.9617.5
Short Term Investments3.13.83.64.10.03.82.73.55.43.1
Total Cash & ST Investments395.8442.1485.4554.9202.5304.0402.8467.6543.3620.6
Accounts Receivable7.710.832.920.824.138.117.110.66.65.8
Inventory0.50.50.50.50.50.024.823.322.224.7
Other Current Assets15.715.77.68.524.534.334.035.336.538.9
Total Current Assets419.8469.1526.4584.7251.6377.9478.8536.8603.2686.9
Long-Term Assets TTM 2024202320222021202020192018
Net Property, Plant & Equipment276.4244.7278.6241.7200.4104.866.845.5
Goodwill0.012.512.512.50.00.00.00.0
Intangible Assets0.012.715.919.313.214.15.76.2
Long-Term Investments0.00.00.00.00.51.00.00.7
Other Long-Term Assets1.71.51.71.71.21.11.00.0
Total Long-Term Assets305.4276.4309.9276.4218.2121.573.452.6
Total Assets557.2802.8788.2860.51,158.21,511.4130.6125.7
Long-Term Assets 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Net Property, Plant & Equipment238.4241.0244.7241.5276.4279.0278.9272.2261.6253.2
Goodwill0.00.012.512.50.00.012.50.00.0-0.1
Intangible Assets7.724.712.712.726.831.315.930.531.730.7
Long-Term Investments0.00.00.00.00.00.015.90.00.00.0
Other Long-Term Assets1.51.51.51.52.01.7-14.21.71.71.7
Total Long-Term Assets269.1273.2276.4269.5305.3312.5310.1305.7296.3286.8
Total Assets688.9742.3802.8854.2556.8690.4788.9842.6899.5973.7
Current Liabilities TTM 2024202320222021202020192018
Accounts Payable7.517.346.468.2122.317.65.39.0
Short-Term Debt5.15.35.05.03.53.22.00.2
Other Current Liabilities49.031.588.046.2176.368.813.313.1
Current Liabilities110.172.3186.4156.2357.7247.628.128.1
Current Liabilities 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Accounts Payable7.69.417.313.47.518.546.412.613.415.0
Short-Term Debt4.95.25.35.25.15.15.05.55.25.1
Other Current Liabilities37.328.231.549.496.6143.9134.5131.9137.069.7
Current Liabilities68.061.372.394.4110.0167.9186.5150.7156.390.3
Long-Term Liabilities TTM 2024202320222021202020192018
Long-Term Debt34.033.636.837.125.426.977.10.0
Capital Leases34.039.041.842.128.930.114.10.0
Def. Tax Liability0.00.20.00.00.00.01.60.0
Total Liabilities180.4106.2271.3327.2469.8800.0173.493.6
Long-Term Liabilities 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Long-Term Debt31.132.233.634.934.035.636.836.635.336.1
Capital Leases36.037.439.040.139.040.636.842.140.541.1
Def. Tax Liability0.20.20.20.00.00.0-48.10.00.00.0
Total Liabilities102.595.6106.2129.5180.3243.5271.5240.3250.4260.3
Total Common Equity TTM 2024202320222021202020192018
Common Stock26.926.926.923.422.521.70.70.7
Retained Earnings-1,710.1-1,403.8-1,566.0-1,305.8-1,056.8-645.1-515.9-416.1
Comprehensive Income-0.12,073.52,056.01,817.11,728.61,334.8472.4447.4
Total Common Equity376.8696.6516.9533.3688.5711.3-42.832.1
Total Common Equity 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Common Stock27.027.026.926.926.926.926.926.926.926.9
Retained Earnings-1,515.4-1,455.9-1,403.8-1,371.0-1,709.1-1,636.5-1,567.3-1,479.3-1,430.6-1,363.2
Comprehensive Income2,074.82,075.62,073.52,068.82,058.72,056.5-0.12,054.72,052.82,050.1
Total Common Equity586.4646.7696.6724.7376.5446.9517.4602.3649.0713.4
Other TTM 2024202320222021202020192018
Total Debt39.139.041.842.128.930.179.10.0
Book Value376.8696.6516.9533.3688.5711.3-42.832.1
Other 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value586.4646.7696.6724.7376.5446.9517.4602.3649.0713.4
Cash Flow From Operating Activities TTM 2024202320222021202020192018
Net Income-275.9190.9-260.2-249.2-412.5-129.8-100.1-71.1
Depreciation & Amortization25.718.823.423.715.710.77.23.8
Stock-Based Compensation4.94.17.79.215.014.219.6-4.2
Change Working Capital-66.9-164.0-68.3-125.6-69.5578.6-22.7-1.1
Change In Accounts Receivable-17.511.5-7.9-16.7-19.8-32.3-10.1-5.6
Change In Accounts Payable59.6-140.6-29.4-96.2179.3620.3-9.69.4
Change In Inventories-41.00.6-47.0-47.9-227.5-8.3-3.20.9
Other Non-cash Items36.052.029.557.2-480.751.69.9-1.5
Cash from Operations-285.90.0-267.9-286.2-733.1522.4-87.0-74.1
Cash Flow From Operating Activities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Income307.6-60.0-51.7-38.6370.6-72.9-69.9-84.4-48.7-67.4
Depreciation & Amortization4.44.44.64.34.55.14.99.15.95.6
Stock-Based Compensation1.51.51.21.31.11.20.51.41.73.0
Change Working Capital-287.412.55.8-50.1-54.4-13.1-46.47.1-15.2-10.3
Change In Accounts Receivable-429.44.114.70.218.3-6.9-0.1-6.3-4.2-0.7
Change In Accounts Payable0.00.00.00.00.00.00.055.54.20.7
Change In Inventories0.00.00.0-0.10.02.1-1.4-39.8-1.9-3.0
Other Non-cash Items3.9-0.5-1.316.532.3-9.1-3.437.2-5.4-4.4
Cash from Operations0.00.00.00.00.00.00.0-40.0-60.6-64.1
Cash Flow From Investing Activities TTM 2024202320222021202020192018
Capital Expenditure-39.6-14.3-52.3-93.2-127.9-47.4-12.2-14.7
Acquisitions0.00.00.0-0.30.00.00.00.0
Investments0.00.00.00.00.0-1.20.00.0
Sales of Investment0.00.00.00.00.00.038.110.5
Other Investing Activities-2.70.0-2.90.00.03.22.30.0
Cash from Investing-39.60.0-55.2-93.5-127.9-45.328.2-4.3
Cash Flow From Investing Activities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Capital Expenditure-0.2-0.7-0.5-2.5-3.3-3.4-5.1-13.6-13.4-14.2
Acquisitions0.00.00.00.00.00.00.00.00.00.0
Investments0.00.00.00.00.00.00.00.00.00.0
Sales of Investment0.00.00.00.00.00.00.00.00.00.0
Other Investing Activities0.00.00.00.00.00.00.0-0.3-2.50.0
Cash from Investing0.00.00.00.00.00.00.0-13.6-13.4-14.2
Cash Flow From Financing Activities TTM 2024202320222021202020192018
Debt Repaid-5.10.0-5.2-4.2-28.2-97.7-1.9-0.1
Debt Issued3.7-2.94.917.427.048.781.10.1
Issuance of Common Stock-2.30.0236.166.5404.1867.70.00.0
Repurchase of Common Stock-0.20.00.00.0-34.10.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.0
Other Financing Activities-0.10.00.00.93.249.969.90.0
Cash from Financing-7.50.0230.963.2345.0819.868.0-0.1
Cash Flow From Financing Activities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Debt Repaid0.00.00.00.00.00.00.0-1.2-1.4-1.3
Debt Issued36.0-1.3-1.6-1.21.1-1.6-1.21.03.10.6
Issuance of Common Stock0.00.00.00.00.00.00.00.00.20.2
Repurchase of Common Stock0.00.00.00.0-0.10.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.0-0.1
Cash from Financing0.00.00.00.00.00.00.0-4.0-1.2-1.2
Cash position TTM 2024202320222021202020192018
Net Change in Cash-336.079.3-93.3-315.7-511.11,291.99.3-78.3
Closing Cash Balance202.6481.7402.5495.8811.51,322.630.721.4
Cash position 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Change in Cash23.4-45.6-43.4-69.1348.3-97.6-102.3-62.1-73.8-79.6
Closing Cash Balance416.1392.7438.3481.7550.9202.5300.2402.8464.1537.9
Free Cash Flow TTM 2024202320222021202020192018
Free Cash Flow-325.483.4-323.1-379.4-861.0475.1-99.2-88.8
Real Free Cash Flow-330.379.3-330.8-388.6-876.0460.8-118.8-84.6
Free Cash Flow 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Free Cash Flow29.5-43.6-41.9-69.1350.8-96.3-101.6-53.5-74.0-78.3
Real Free Cash Flow28.1-45.2-43.0-70.4349.7-97.5-102.1-55.0-75.7-81.3
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E8.1-23.6-1.4
P/S14.881.79.4
P/B1.81.35.2
P/FCF-8-69.3-1.5
Market cap$1.2$1.5
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets5.2 %8.5 %0 %
Debt to Income28 %-18.5 %0 %
Debt to Free cash flow-27.6 %-531.6 %0 %
Interest expense percentage4.8 %-4 %44.7 %
Current ratio6.2 3.2 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE22 %-11.6 %0 %
ROA18.7 %-21.2 %0 %
CapEx to Revenue1.4 %88.2 %0 %
RaD to Revenue0 %314.1 %0 %
ROEM71,964.4 49626.2

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin94.8 %-98.3 %68.7 %
Operating margin40.8 %-450 %35.5 %
Net margin37.9 %-449.2 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding225.2 mil 185.7 mil
Employee count1.0 tis 0.9 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás
Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader